Needham Reiterates Buy Rating on Nurix Therapeutics, Keeps $34 Price Target
Needham reiterated its Buy rating and $34.00 price target on Nurix Therapeutics. The target implies 53.4% upside from the Oct. 12 close of $22.16.
Needham reiterated its Buy rating and $34.00 price target on Nurix Therapeutics. The target implies 53.4% upside from the Oct. 12 close of $22.16.